Departamento de Bioquímica y Biología Molecular I, Facultad de Biología, Universidad Complutense de Madrid, 28040-Madrid, Spain.
FASEB J. 2010 Oct;24(10):3662-73. doi: 10.1096/fj.09-142646. Epub 2010 May 19.
The purpose of this study was to investigate how surfactant membranes can be perturbed by C-reactive protein (CRP) and whether surfactant protein A (SP-A) might overcome CRP-induced surfactant membrane alterations. The effect of CRP on surfactant surface adsorption was evaluated in vivo after intratracheal instillation of CRP into rat lungs. Insertion of CRP into surfactant membranes was investigated through monolayer techniques. The effect of CRP on membrane structure was studied through differential scanning calorimetry and fluorescence spectroscopy and microscopy using large and giant unilamellar vesicles. Our results indicate that CRP inserts into surfactant membranes and drastically increases membrane fluidity, resulting in surfactant inactivation. At 10% CRP/phospholipid weight ratio, CRP causes disappearance of liquid-ordered/liquid-disordered phase coexistence distinctive of surfactant membranes. SP-A, the most abundant surfactant lipoprotein structurally similar to C1q, binds to CRP (K(d)=56±8 nM), as determined by solid-phase binding assays and dynamic light scattering. This novel SP-A/CRP interaction reduces CRP insertion and blocks CRP effects on surfactant membranes. In addition, intratracheal coinstillation of SP-A+CRP into rat lungs prevents surfactant inhibition induced by CRP, indicating that SP-A/CRP interactions might be an important factor in vivo in controlling harmful CRP effects in the alveolus.
本研究旨在探讨 C 反应蛋白 (CRP) 如何影响表面活性剂膜,以及表面活性剂蛋白 A (SP-A) 是否可以克服 CRP 引起的表面活性剂膜改变。通过向大鼠肺内气管内滴注 CRP,评估 CRP 对表面活性剂表面吸附的体内影响。通过单层技术研究 CRP 对膜结构的影响。通过差示扫描量热法和荧光光谱法以及使用大的和巨大的单层囊泡进行显微镜研究,研究 CRP 对膜结构的影响。我们的结果表明,CRP 插入表面活性剂膜并极大地增加膜流动性,导致表面活性剂失活。在 10% CRP/磷脂重量比下,CRP 导致表面活性剂膜特有的液有序/液无序相共存消失。作为结构上类似于 C1q 的最丰富的表面活性剂脂蛋白,SP-A 通过固相结合测定和动态光散射与 CRP 结合(K(d)=56±8 nM)。这种新型的 SP-A/CRP 相互作用减少了 CRP 的插入,并阻止了 CRP 对表面活性剂膜的作用。此外,向大鼠肺内气管内同时滴注 SP-A+CRP 可防止 CRP 引起的表面活性剂抑制,表明 SP-A/CRP 相互作用可能是肺泡内控制有害 CRP 作用的重要体内因素。